menu close
www.outpacebio.com

Outpace Bio Stock

Company Profile:

Outpace Bio is pioneering advancements in cell therapy by leveraging AI-powered protein design to program immune cells for enhanced functionality within patients. Their innovative approach addresses key challenges in treating solid tumors, such as improving tumor access, cell survival, and immune response. By creating modular, plug-and-play protein assets, the company develops engineered T cell therapies aimed at achieving unprecedented efficacy in combating cancer.

Sign up for SecondMarket® to view the market and buy or sell Outpace Bio Stock
Buy + Sell
  • Headquarters: Seattle, WA
  • Year Founded: 2019
  • Sector: Health Care
Leverage Your Equity to Help Achieve More.

Outpace Bio Management Team

  • Chief Business Officer

    Eric Soller

  • Chief Scientific Officer

    Aaron Foster

  • Board Member, Co-Founder, CTO

    Scott Boyken

  • Board Member

    Jake Simson

  • Chief Development Officer

    Charity Scripture

  • Board Member

    Bahija Jallal

  • Board Member

    Vasudev Bailey

  • Board Member, Co-Founder, CEO

    Marc Lajoie

Learn More About Outpace Bio Stock

Buy Outpace Bio Stock
01

Outpace Bio stock does not trade on public stock exchanges. Outpace Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Outpace Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Outpace Bio Stock
02

Outpace Bio Stock does not trade on public stock exchanges. In order to sell Outpace Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Outpace Bio Stock Price
03

Outpace Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Outpace Bio share price and other valuable private market data.

Read more about secondary market private company stock prices:

Outpace Bio Stock Ticker Symbol
04

There is no ticker symbol for Outpace Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Outpace Bio Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Outpace Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Outpace Bio Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Outpace Bio stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Outpace Bio Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Outpace Bio IPO
08

Outpace Bio is a private company and has not had an IPO. There is currently no Outpace Bio IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Outpace Bio IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell Outpace Bio Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Cityblock Health-Logo

Cityblock Health

Tech-driven care provider for communities with complex needs.

Benchling-Logo

Benchling

Cloud based platform for research and development in biotechnology.

Insitro-Logo

insitro

Drug discovery and development company.

Lyra Healthcare-Logo

Lyra

Digital health startup using technology to connect companies and employees to mental health providers.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Tonal Strong-Logo

Tonal

Developed a fitness system, called Tonal, that combines revolutionary equipment, expert-led videos, and personalized guidance into full body workouts users can do on demand from the convenience of home.

Cerebral

Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Curology-Logo

Curology

Offers personalized prescription skin care medications delivered directly to you.

Source: Nasdaq Private Market Tape D®